# Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy

> **NCT07409298** · NA · ENROLLING_BY_INVITATION · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 300 (estimated)

## Conditions studied

- CDK4/6 Inhibitors
- Depression Anxiety Disorder
- Breast Cancer

## Interventions

- **DEVICE:** The "Zhiliao Doctor" AI management platform
- **BEHAVIORAL:** Tailored Active Follow-up Strategy

## Key facts

- **NCT ID:** NCT07409298
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-07-05
- **Primary completion:** 2026-05-24
- **Final completion:** 2026-05-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07409298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07409298, "Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07409298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*